OneStudyTeam, a clinical trial workflow platform under parent company Reify Health, laid off 160 employees in December 2022, representing about a quarter of its workforce. The company cited a need to restructure and streamline operations after a period of extremely rapid growth and hiring. This move came despite Reify Health having secured significant funding earlier in the year, including a $220 million Series D round in April that valued the company at $4.8 billion. OneStudyTeam operates in the health tech industry, providing cloud-based software to accelerate clinical trials.
